ShockWave Medical, Inc.
SWAV · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $730,230 | $489,733 | $237,146 | $67,789 |
| % Growth | 49.1% | 106.5% | 249.8% | – |
| Cost of Goods Sold | $95,388 | $64,996 | $41,438 | $20,991 |
| Gross Profit | $634,842 | $424,737 | $195,708 | $46,798 |
| % Margin | 86.9% | 86.7% | 82.5% | 69% |
| R&D Expenses | $145,647 | $81,679 | $50,544 | $36,926 |
| G&A Expenses | $95,265 | $56,929 | $34,747 | $23,863 |
| SG&A Expenses | $330,102 | $218,924 | $146,035 | $75,535 |
| Sales & Mktg Exp. | $234,837 | $161,995 | $111,288 | $51,672 |
| Other Operating Expenses | $23,962 | $1,055 | -$582 | $0 |
| Operating Expenses | $468,849 | $300,603 | $196,579 | $112,461 |
| Operating Income | $165,993 | $124,134 | -$871 | -$65,663 |
| % Margin | 22.7% | 25.3% | -0.4% | -96.9% |
| Other Income/Exp. Net | $8,288 | -$3,306 | -$7,964 | $44 |
| Pre-Tax Income | $174,281 | $120,828 | -$8,835 | -$65,619 |
| Tax Expense | $27,003 | -$95,168 | $301 | $80 |
| Net Income | $147,278 | $215,996 | -$9,136 | -$65,699 |
| % Margin | 20.2% | 44.1% | -3.9% | -96.9% |
| EPS | 4.01 | 6.02 | -0.26 | -1.99 |
| % Growth | -33.4% | 2,415.4% | 86.9% | – |
| EPS Diluted | 3.85 | 5.7 | -0.26 | -1.99 |
| Weighted Avg Shares Out | 36,706 | 35,901 | 35,098 | 33,088 |
| Weighted Avg Shares Out Dil | 38,206 | 37,882 | 35,098 | 33,088 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1,886 | $1,096 | $1,212 |
| Interest Expense | $6,195 | $1,886 | $1,096 | $1,212 |
| Depreciation & Amortization | $10,358 | -$1,420 | -$6,868 | $1,256 |
| EBITDA | $190,834 | $127,570 | -$871 | -$63,151 |
| % Margin | 26.1% | 26% | -0.4% | -93.2% |